Varenicline: cardiovascular safety
- Varenicline: quantifying the risk. Blankfield, Robert P.; Takagi, Hisato; Umemoto, Takuya; Woods, David J.; Caswell, Mark D.; Squire, Edward N.; Alper, Brian S.; Singh, Sonal; Loke, Yoon K.; Spangler, John G.; Furberg, Curt D. // CMAJ: Canadian Medical Association Journal;9/6/2011, Vol. 183 Issue 12, p1404
Several letters to the editor are presented in response to the article "Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis," by Sonal Singh and colleagues, as well as a response to the said letters to the editor.
- Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Events. Lewis, Evan J. H.; Sethi, Ankur; Singh, Mukesh; Arora, Rohit; Vlachopoulos, Charalambos; Richter, Dimitrios; Stefanadis, Christodoulos; Galli, Claudio; Brenna, J. Thomas; Rizos, Evangelos C.; Ntzani, Evangelia E. // JAMA: Journal of the American Medical Association;1/2/2013, Vol. 309 Issue 1, p27
Several letters to the editor is presented in response to the article "Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis" by E.C. Rizos and colleagues in a 2012 issue of the periodical along with response...
- ACE Inhibitors Versus ARBs Versus DRIs: A Systematic Update. Smetana, Gerald // JGIM: Journal of General Internal Medicine;Dec2012, Vol. 27 Issue 12, p1586
A response from the author of "Newer is Not Always Better: All Antihypertensive Medications do not Equally Reduce Cardiovascular Risk" published in earlier issue of the journal is presented.
- Effects of a Low-Carbohydrate Diet. Hays, James H. // Mayo Clinic Proceedings;Mar2004, Vol. 79 Issue 3, p431
Presents a letter to the editor, on the role of low-carbohydrate diet in reducing risk factors for cardiovascular diseases, published in the March 12, 2004 issue of the periodical "Mayo Clinic Proceedings."
- Ergo-anthropometric Assessment. Salinas, Alberto Morales; Coca, Antonio; Lavie, Carl J.; Sierra-Johnson, Justo // Mayo Clinic Proceedings;Oct2009, Vol. 84 Issue 10, p940
A letter to the editor and a reply are presented in response to the article "Obesity and Cardiovascular Diseases: Risk Factor, Paradox, and Impact of Weight Loss" by Carl J. Lavie in the previous issue.
- Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy. Roy, Parthasarathi // Indian Journal of Ophthalmology;Jan2013, Vol. 61 Issue 1, p40
A letter to the editor in response to the article "Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy," published in a previous issue of the periodical is presented.
- Western model hands drugs to the lazy. Hodkinson, Alice // Pulse;1/26/2011, Vol. 71 Issue 3, p11
A letter to the editor is presented in response to the article on "JBS to rip up Rules on Cardiovascular Risk" in the previous issue.
- THREE AUTHORS REPLY. Rich-Edwards, Janet W.; Manson, Joann E.; Hennekens, Charles H. // American Journal of Epidemiology;1996, Vol. 144 Issue 7, p708
A response from the authors is presented to a letter to the editor by Mary Walker and colleagues about their article "Height and the risk of cardiovascular disease in women" in a previous issue.
- Milk: Getting to the heart of it. // Irish Farmers Monthly;Jan2011, p48
The article focuses on the meta-analysis which examined the association of milk with the risk of total mortality and cardiovascular disease (CVD), in which the results showed that milk has an inverse relationship with CVD risk, while, mortality and coronary heart disease (CHD) showed no connection.